US Stock MarketDetailed Quotes

COGT Cogent Biosciences

Watchlist

7.610
+0.260+3.54%

Trading May 14 10:36 ET

727.62MMarket Cap-3056P/E (TTM)

Cogent Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-32.93%-52.53M

-29.49%-153.62M

-49.86%-44.07M

-10.25%-37.97M

-21.21%-32.07M

-39.47%-39.52M

-101.89%-118.64M

-41.54%-29.41M

-144.10%-34.44M

-111.46%-26.46M

Net income from continuing operations

-51.21%-58.35M

-37.20%-192.41M

-37.22%-54.37M

-57.95%-55.38M

-26.19%-44.08M

-25.96%-38.59M

-94.04%-140.24M

-59.03%-39.62M

-83.72%-35.06M

-111.05%-34.93M

Operating gains losses

----

--8K

----

Depreciation and amortization

47.44%1.07M

-38.96%3.59M

-15.26%794K

-76.96%855K

81.49%1.22M

29.11%723K

195.23%5.88M

71.61%937K

621.98%3.71M

-26.70%670K

Other non cash items

----

-25.00%-1.7M

--0

---1.7M

-296.50%-1.36M

----

Change In working capital

31.85%-3.24M

1,423.57%11.44M

-27.06%4.94M

200.45%6.89M

33.70%4.37M

-95.48%-4.76M

326.70%751K

2,677.19%6.78M

-787.27%-6.86M

511.80%3.27M

-Change in prepaid assets

-248.73%-1.1M

57.87%-626K

13.35%1.85M

18.91%-1.79M

-114.53%-369K

57.12%-316K

-554.63%-1.49M

-2.04%1.63M

-61.20%-2.21M

91.02%-172K

-Change in payables and accrued expense

57.18%-1.81M

8.69%12.98M

-38.51%3.42M

179.12%8.96M

97.39%4.84M

-678.25%-4.23M

93.22%11.95M

1,770.03%5.55M

8.45%3.21M

-54.37%2.45M

-Change in other current assets

93.33%-2K

88.31%-119K

-108.70%-2K

-168.50%-87K

--0

98.40%-30K

72.69%-1.02M

101.36%23K

292.42%127K

129.43%711K

-Change in other current liabilities

-76.47%-330K

90.84%-796K

25.93%-320K

97.65%-188K

-136.46%-101K

66.00%-187K

-323.49%-8.69M

19.40%-432K

-1,423.85%-7.99M

154.64%277K

Cash from discontinued investing activities

Operating cash flow

-32.93%-52.53M

-29.49%-153.62M

-49.86%-44.07M

-10.25%-37.97M

-21.21%-32.07M

-39.47%-39.52M

-101.89%-118.64M

-41.54%-29.41M

-144.10%-34.44M

-111.46%-26.46M

Investing cash flow

Cash flow from continuing investing activities

-98.26%1.04M

21.56%-97.82M

-63.08%10.49M

40.26%-90.54M

-6,688.55%-77.66M

13,679.14%59.88M

-7,155.26%-124.72M

6,661.43%28.41M

-12,930.44%-151.54M

-830.08%-1.14M

Net PPE purchase and sale

93.65%-70K

59.26%-2.8M

83.99%-315K

96.35%-121K

-9.88%-1.26M

-150.11%-1.1M

-299.24%-6.86M

-354.27%-1.97M

-184.69%-3.31M

-830.08%-1.14M

Net investment purchase and sale

-98.17%1.11M

19.37%-95.03M

-64.43%10.8M

39.00%-90.42M

---76.4M

--60.99M

---117.86M

--30.38M

---148.23M

--0

Cash from discontinued investing activities

Investing cash flow

-98.26%1.04M

21.56%-97.82M

-63.08%10.49M

40.26%-90.54M

-6,688.55%-77.66M

13,679.14%59.88M

-7,155.26%-124.72M

6,661.43%28.41M

-12,930.44%-151.54M

-830.08%-1.14M

Financing cash flow

Cash flow from continuing financing activities

48,002.70%214.06M

-0.01%163.54M

1.01%1M

-0.01%162.09M

222.46%445K

330.69%163.56M

-99.17%315K

1,700.00%990K

162.12M

Net common stock issuance

--213.7M

-0.08%161.82M

--0

0.00%-170K

--161.99M

--0

326.10%161.95M

--0

---170K

----

Proceeds from stock option exercised by employees

-20.00%356K

6.45%1.72M

--0

0.86%1.17M

--102K

222.46%445K

2,832.73%1.61M

--315K

2,009.09%1.16M

--0

Cash from discontinued financing activities

Financing cash flow

48,002.70%214.06M

-0.01%163.54M

--0

1.01%1M

-0.01%162.09M

222.46%445K

330.69%163.56M

-99.17%315K

1,700.00%990K

--162.12M

Net cash flow

Beginning cash position

-62.29%53.23M

-36.12%141.14M

-38.79%86.81M

-34.42%214.32M

-15.78%161.95M

-36.12%141.14M

-9.24%220.94M

-30.53%141.82M

48.99%326.82M

-17.11%192.3M

Current changes in cash

681.15%162.57M

-10.17%-87.91M

-4,823.90%-33.58M

31.08%-127.51M

-61.07%52.36M

172.68%20.81M

-254.56%-79.8M

-104.06%-682K

-1,115.71%-184.99M

1,164.71%134.52M

End cash Position

33.25%215.8M

-62.29%53.23M

-38.79%86.81M

-34.42%214.32M

-15.78%161.95M

-36.12%141.14M

-30.53%141.82M

48.99%326.82M

Free cash flow

-29.49%-52.6M

-24.64%-156.42M

-41.47%-44.39M

-0.90%-38.09M

-20.74%-33.32M

-41.16%-40.62M

-107.50%-125.5M

-47.93%-31.38M

-147.19%-37.75M

-118.46%-27.6M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-32.93%-52.53M	-29.49%-153.62M	-49.86%-44.07M	-10.25%-37.97M	-21.21%-32.07M	-39.47%-39.52M	-101.89%-118.64M	-41.54%-29.41M	-144.10%-34.44M	-111.46%-26.46M
Net income from continuing operations	-51.21%-58.35M	-37.20%-192.41M	-37.22%-54.37M	-57.95%-55.38M	-26.19%-44.08M	-25.96%-38.59M	-94.04%-140.24M	-59.03%-39.62M	-83.72%-35.06M	-111.05%-34.93M
Operating gains losses	----	--8K	----	----	----	----	----	----	----	----
Depreciation and amortization	47.44%1.07M	-38.96%3.59M	-15.26%794K	-76.96%855K	81.49%1.22M	29.11%723K	195.23%5.88M	71.61%937K	621.98%3.71M	-26.70%670K
Other non cash items	----	-25.00%-1.7M	--0	--0	--0	---1.7M	-296.50%-1.36M	----	----	----
Change In working capital	31.85%-3.24M	1,423.57%11.44M	-27.06%4.94M	200.45%6.89M	33.70%4.37M	-95.48%-4.76M	326.70%751K	2,677.19%6.78M	-787.27%-6.86M	511.80%3.27M
-Change in prepaid assets	-248.73%-1.1M	57.87%-626K	13.35%1.85M	18.91%-1.79M	-114.53%-369K	57.12%-316K	-554.63%-1.49M	-2.04%1.63M	-61.20%-2.21M	91.02%-172K
-Change in payables and accrued expense	57.18%-1.81M	8.69%12.98M	-38.51%3.42M	179.12%8.96M	97.39%4.84M	-678.25%-4.23M	93.22%11.95M	1,770.03%5.55M	8.45%3.21M	-54.37%2.45M
-Change in other current assets	93.33%-2K	88.31%-119K	-108.70%-2K	-168.50%-87K	--0	98.40%-30K	72.69%-1.02M	101.36%23K	292.42%127K	129.43%711K
-Change in other current liabilities	-76.47%-330K	90.84%-796K	25.93%-320K	97.65%-188K	-136.46%-101K	66.00%-187K	-323.49%-8.69M	19.40%-432K	-1,423.85%-7.99M	154.64%277K
Cash from discontinued investing activities
Operating cash flow	-32.93%-52.53M	-29.49%-153.62M	-49.86%-44.07M	-10.25%-37.97M	-21.21%-32.07M	-39.47%-39.52M	-101.89%-118.64M	-41.54%-29.41M	-144.10%-34.44M	-111.46%-26.46M
Investing cash flow
Cash flow from continuing investing activities	-98.26%1.04M	21.56%-97.82M	-63.08%10.49M	40.26%-90.54M	-6,688.55%-77.66M	13,679.14%59.88M	-7,155.26%-124.72M	6,661.43%28.41M	-12,930.44%-151.54M	-830.08%-1.14M
Net PPE purchase and sale	93.65%-70K	59.26%-2.8M	83.99%-315K	96.35%-121K	-9.88%-1.26M	-150.11%-1.1M	-299.24%-6.86M	-354.27%-1.97M	-184.69%-3.31M	-830.08%-1.14M
Net investment purchase and sale	-98.17%1.11M	19.37%-95.03M	-64.43%10.8M	39.00%-90.42M	---76.4M	--60.99M	---117.86M	--30.38M	---148.23M	--0
Cash from discontinued investing activities
Investing cash flow	-98.26%1.04M	21.56%-97.82M	-63.08%10.49M	40.26%-90.54M	-6,688.55%-77.66M	13,679.14%59.88M	-7,155.26%-124.72M	6,661.43%28.41M	-12,930.44%-151.54M	-830.08%-1.14M
Financing cash flow
Cash flow from continuing financing activities	48,002.70%214.06M	-0.01%163.54M	0	1.01%1M	-0.01%162.09M	222.46%445K	330.69%163.56M	-99.17%315K	1,700.00%990K	162.12M
Net common stock issuance	--213.7M	-0.08%161.82M	--0	0.00%-170K	--161.99M	--0	326.10%161.95M	--0	---170K	----
Proceeds from stock option exercised by employees	-20.00%356K	6.45%1.72M	--0	0.86%1.17M	--102K	222.46%445K	2,832.73%1.61M	--315K	2,009.09%1.16M	--0
Cash from discontinued financing activities
Financing cash flow	48,002.70%214.06M	-0.01%163.54M	--0	1.01%1M	-0.01%162.09M	222.46%445K	330.69%163.56M	-99.17%315K	1,700.00%990K	--162.12M
Net cash flow
Beginning cash position	-62.29%53.23M	-36.12%141.14M	-38.79%86.81M	-34.42%214.32M	-15.78%161.95M	-36.12%141.14M	-9.24%220.94M	-30.53%141.82M	48.99%326.82M	-17.11%192.3M
Current changes in cash	681.15%162.57M	-10.17%-87.91M	-4,823.90%-33.58M	31.08%-127.51M	-61.07%52.36M	172.68%20.81M	-254.56%-79.8M	-104.06%-682K	-1,115.71%-184.99M	1,164.71%134.52M
End cash Position	33.25%215.8M	-62.29%53.23M	-62.29%53.23M	-38.79%86.81M	-34.42%214.32M	-15.78%161.95M	-36.12%141.14M	-36.12%141.14M	-30.53%141.82M	48.99%326.82M
Free cash flow	-29.49%-52.6M	-24.64%-156.42M	-41.47%-44.39M	-0.90%-38.09M	-20.74%-33.32M	-41.16%-40.62M	-107.50%-125.5M	-47.93%-31.38M	-147.19%-37.75M	-118.46%-27.6M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall